Early Effects of a Pain-Informed Movement Program in Patients with Post-COVID-19 Condition Experiencing Persistent Pain: Protocol for a Randomized Controlled Trial
Metadatos
Afficher la notice complèteAuteur
Calvache Mateo, Andrés; López López, Laura; Heredia Ciuró, Alejandro; Martín-Núñez, Javier; Valenza Peña, Geraldine; Cabrera Martos, Irene; Valenza, Marie CarmenEditorial
MDPI
Materia
Post COVID-19 condition Pain Informed Movement program Protocol
Date
2024-01-20Referencia bibliográfica
Calvache-Mateo, A.; López-López, L.; Heredia-Ciuró, A.; Martín-Núñez, J.; Valenza-Peña, G.; Cabrera-Martos, I.; Valenza, M.C. Early Effects of a Pain-Informed Movement Program in Patients with Post-COVID-19 Condition Experiencing Persistent Pain: Protocol for a Randomized Controlled Trial. J. Clin. Med. 2024, 13, 597. https://doi.org/10.3390/jcm13020597
Patrocinador
Spanish Ministry of Education (Grant numbers FPU: 21/00451, FPU 20/01670, and FPU 19/02609); College of Physiotherapists of Andalucia, Proyect Ref: 06195/21D/MARésumé
(1) Background: The COVID-19 pandemic has generated 771 million confirmed cases. Of
these patients, 60% have developed persistent symptoms including pain. This pain is a complex
symptom that needs comprehensive therapeutic strategies to address it holistically. The main objective
of this study will be to evaluate the early impact of the Pain Informed Movement (PIM) program
in patients with post-COVID-19 conditions experiencing new-onset persistent pain. (2) Methods: A
randomized, single-blind clinical trial will be performed. Patients will be randomly assigned (1:1) to
the experimental or control group. The experimental group will undergo a PIM program consisting
of low-intensity functional exercises, pain neuroscience education, and relaxation techniques. The
control group will receive no intervention. (3) Results: The results will be published as a peerreviewed
article. (4) Conclusions: This study will provide a basis for future research to support the
implementation of comprehensive therapeutic approaches in the care of patients with post-COVID-19
persistent pain.